SCHEMBL4649870

SCHEMBL4649870

COc1cccc(-c2cc(=O)c3cc(O)ccc3o2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 1.00
CYP3A4 P08684 8/20 1.00
TP53 P04637 6/20 1.00
KDM4E B2RXH2 5/20 1.00
MEN1 O00255 4/20 1.00
KMT2A Q03164 4/20 1.00
CYP2C19 P33261 4/20 1.00
MAPK1 P28482 3/20 1.00
CYP2C9 P11712 3/20 1.00
TSHR P16473 3/20 1.00
CSNK2A2 P19784 6/20 0.74
CSNK2B P67870 6/20 0.74
CSNK2A1 P68400 6/20 0.74
NPC1 O15118 4/20 0.74
RAB9A P51151 4/20 0.74
RECQL P46063 2/20 0.74
NFKB1 P19838 2/20 0.74
NFKB2 Q00653 2/20 0.74
RELA Q04206 2/20 0.74
HPGD P15428 7/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31675975 1.00 MAPT (1.00) MAPTCYP3A4TP53KDM4EMEN1
SCHEMBL4650072 0.90 CYP3A4 (0.82) MAPTCYP3A4TP53KDM4EMEN1
6,3'-Dimethoxyflavone SCHEMBL516389 0.89 KDM4E (0.82) MAPTCYP3A4TP53KDM4EMEN1
6,3'-Dimethoxyflavone SCHEMBL30894690 0.89 KDM4E (0.82) MAPTCYP3A4TP53KDM4EMEN1
SCHEMBL31238517 0.86 MAPT (0.76) MAPTCYP3A4TP53KDM4EMEN1
SCHEMBL31387543 0.85 KDM4E (0.74) MAPTCYP3A4TP53KDM4EMEN1
SCHEMBL31675989 0.85 MAPT (1.00) MAPTCYP3A4TP53KDM4EMEN1
SCHEMBL490928 0.85 MAPT (1.00) MAPTCYP3A4TP53KDM4EMEN1
SCHEMBL4277649 0.85 MAPT (1.00) MAPTCYP3A4TP53KDM4EMEN1
SCHEMBL7079959 0.85 KDM4E (0.73) MAPTCYP3A4TP53KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US claimed
EP-2730431-B1 Rubber composition and tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2017-06-28 EP disclosed
US-20140135433-A1 TIRE WITH RUBBER CONTAINING FLAVONE THE GOODYEAR TIRE & RUBBER COMPANY (US) 2014-05-15 US disclosed
EP-2730431-A1 Rubber composition and tire with rubber containing flavone The Goodyear Tire & Rubber Company (US) 2014-05-14 EP disclosed
EP-1391327-B1 Tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2008-09-03 EP disclosed
US-20070254859-A1 Compounds exhibiting efflux inhibitor activity and composition and uses thereof EASTMAN CHEMICAL COMPANY 2007-11-01 US disclosed
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US disclosed
EP-1391327-A1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2004-02-25 EP disclosed
WO-2003057210-A1 COMPOSITIONS AND METHODS FOR INCREASING CELL PROLIFERATION COMPRISING A FLAVONOID KIMBERLY-CLARK WORLDWIDE, INC. (US) 2003-07-17 WO disclosed
US-20030125264-A1 Methods For Treating Wounds KIMBERLY-CLARK WORLDWIDE, INC. 2003-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254859-A1 Compounds exhibiting efflux inhibitor activity and composition and uses thereof ABCC4, NCOA4, NR4A3 MAPT 4566/4885CYP3A4 17/4885TP53 3361/4885
US-20030125264-A1 Methods For Treating Wounds FGF2, MMP1, FIBP MAPT 4313/4885CYP3A4 3010/4885TP53 841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.